Back to search

Aristotle University Of Thessaloniki (AUTH)

Biochemical studies on blood coagulation mechanism: effect of recombinant von Willebrand factor-A1 domain on the process of hemostasis

Abstract

dc:description

The hemostatic system is a vital protective mechanism for the control of excessive bleeding after injury in the vascular system, as well as for the prevention of a hypercoagulative state during the coagulation response. One of the most important systems within the human body is the vasculature, because all organs and tissues are dependent on it for survival. Blood is a vital part of the human physiology; a transport system that brings nutrients and oxygen to sustain living cells and simultaneously facilitates the removal of carbon dioxide and metabolic waste products from the tissues of the body. Therefore maintenance of the vascular system, termed hemostasis, is vital for survival and is the controlled arrest of bleeding and maintains vessel integrity with minimal blood loss. To assure the continuity of these functions, it is of uttermost importance to keep the flowing blood inside the vascular system at any cost. The complex process of blood coagulation is driven through a complex enzymatic pathway that involves several zymogen-to-enzyme conversion steps and allows the reaction to undergo great intrinsic amplification. The final step in this cascade is the conversion of soluble fibrinogen into an insoluble fibrin network. Thrombin plays a central role in the coagulation cascade and is the last compound that gets activated. During activation of coagulation, thrombin is the only enzyme that is freely available in blood circulation, where it encounters different substrates. It’s most relevant substrate is fibrinogen which is converted to fibrin by thrombin. Further more, in blood circulation, thrombin can induce physiological but often also pathological processes depending on the amount of available thrombin. Serine protease factor Xa (FXa), which functions principally at coagulation cascades catalyzes the conversion of prothrombin to thrombin at the sites of vascular injury. The serine protease domain of FXa is one of the most effective targets for developing direct anticoagulants for the coagulation disorders. The coagulation process is accelerated in the presence of calcium, and a phospholipid surface that is usually presented by the activated platelets, and will ultimately form a stabilizing fibrin network that will secure the platelet plug until the vessel wall is restored. von Willebrand factor (vWF) is a plasma protein that performs two main functions in hemostasis: it mediates platelet activation and adhesion to the injured vessel wall that leads to the formation of platelet thrombi and the subsequent arrest of bleeding. Furthermore, vWF protects coagulation factor VIII (FVIII) from rapid proteolytic inactivation. Cardiovascular diseases are one of the major causes of morbidity and mortality in the developed nations. Despite the continuous efforts by numerous laboratories all around the world, effective drug targets for diseases such as heart attack and stroke have not yet been identified. As of today this field stands in its early development stages only. There are numerous questions in this field of science which still require answers. As thrombin and FXa plays a fundamental role in the coagulation cascade, it is logical that the calculation of their levels, apart from a number of other important information, constitutes the most appropriate way to study the overall patients’ haemostatic status, therefore helping to monitor the patients’ condition. For example, this approach has recently been used for targeting potential extra-haemostatic effects as well as to identify patients at risk for recurrent venous thromboembolism. This piece of information makes extremely interesting the development of methods for monitoring thrombin and FXa production in vitro. Related to this vast area of science, in the present work we developed extremely simplified methods to determine thrombin and FXa production, which might be automatable. The most widely used chromogenic substrate was applied, several parameters involved in the reaction were examined and optimized in order to establish a rapid routine, less time consuming and suitable method for the evaluation of large numbers of clinical samples. The thrombin and FXa production values were compared in plasma samples before and after clot removal, correlation between FXa and thrombin production values have been calculated and also the effects of physical exercise, platelet count, FVIIa and tissue factor(TF) on thrombin and FXa production have also been carried out. Furthermore routine determination of this factor (Thrombin) in hospitalized diabetic patients under different anti-coagulating therapies have been carried out. As the coagulation cascade proceeds as a series of linked proteolytic reactions, the enzymes generated by these processes are not directly available for quantitative measurement because they are rapidly neutralized by naturally occurring protease inhibitors. To face these obstacles, we have also focused to the development of western blotting techniques in order to study blood clotting FX and its active form. In addition in the frame of this work we have investigated the potential function of purified vWF A1 domain protein in platelet activation and in the natural process of hemostasis in order to fully understand its particular role in maintaining the integrity of the blood coagulation. To this purpose the specific amino acid region (A1 domain) of vWF has been cloned, expressed in mammalian and bacterial cells, purified and used both as bacterial and cellular protein.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2012

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Ahmed, Salar

Subjects

dc:subject × 20

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/28383

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Ahmed, Salar. Biochemical studies on blood coagulation mechanism: effect of recombinant von Willebrand factor-A1 domain on the process of hemostasis. Aristotle University Of Thessaloniki (AUTH), 2012. http://hdl.handle.net/10442/hedi/28383